BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 32078678)

  • 1. Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis.
    Cunha MI; Su M; Cantuti-Castelvetri L; Müller SA; Schifferer M; Djannatian M; Alexopoulos I; van der Meer F; Winkler A; van Ham TJ; Schmid B; Lichtenthaler SF; Stadelmann C; Simons M
    J Exp Med; 2020 May; 217(5):. PubMed ID: 32078678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord.
    Church JS; Milich LM; Lerch JK; Popovich PG; McTigue DM
    Glia; 2017 Jun; 65(6):883-899. PubMed ID: 28251686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remyelination-Promoting Inflammation: Novel Role for MyD88 Signaling in Microglia/Macrophages.
    Murugaiyan G; Fujiwara M; Garo LP
    Trends Neurosci; 2020 Jul; 43(7):455-457. PubMed ID: 32362400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection.
    Sariol A; Mackin S; Allred MG; Ma C; Zhou Y; Zhang Q; Zou X; Abrahante JE; Meyerholz DK; Perlman S
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24464-24474. PubMed ID: 32929007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin.
    Keough MB; Jensen SK; Yong VW
    J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient Surveillance and Phagocytic Activity of Myeloid Cells Within Demyelinated Lesions in Aging Mice Visualized by
    Rawji KS; Kappen J; Tang W; Teo W; Plemel JR; Stys PK; Yong VW
    J Neurosci; 2018 Feb; 38(8):1973-1988. PubMed ID: 29363580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord.
    Kucharova K; Chang Y; Boor A; Yong VW; Stallcup WB
    J Neuroinflammation; 2011 Nov; 8():158. PubMed ID: 22078261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination.
    Shen K; Reichelt M; Kyauk RV; Ngu H; Shen YA; Foreman O; Modrusan Z; Friedman BA; Sheng M; Yuen TJ
    Cell Rep; 2021 Mar; 34(10):108835. PubMed ID: 33691116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination.
    Harrington EP; Zhao C; Fancy SP; Kaing S; Franklin RJ; Rowitch DH
    Ann Neurol; 2010 Nov; 68(5):703-16. PubMed ID: 20853437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.
    Lombardi M; Parolisi R; Scaroni F; Bonfanti E; Gualerzi A; Gabrielli M; Kerlero de Rosbo N; Uccelli A; Giussani P; Viani P; Garlanda C; Abbracchio MP; Chaabane L; Buffo A; Fumagalli M; Verderio C
    Acta Neuropathol; 2019 Dec; 138(6):987-1012. PubMed ID: 31363836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye.
    Baydyuk M; Cha DS; Hu J; Yamazaki R; Miller EM; Smith VN; Kelly KA; Huang JK
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14290-14299. PubMed ID: 31235582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.
    Brück W; Pförtner R; Pham T; Zhang J; Hayardeny L; Piryatinsky V; Hanisch UK; Regen T; van Rossum D; Brakelmann L; Hagemeier K; Kuhlmann T; Stadelmann C; John GR; Kramann N; Wegner C
    Acta Neuropathol; 2012 Sep; 124(3):411-24. PubMed ID: 22766690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the Benefits of Neuroinflammation: Generation of Macrophages/Microglia with Prominent Remyelinating Properties.
    Mishra MK; Rawji KS; Keough MB; Kappen J; Dowlatabadi R; Vogel HJ; Chopra S; Distéfano-Gagné F; Dufour A; Gosselin D; Yong VW
    J Neurosci; 2021 Apr; 41(15):3366-3385. PubMed ID: 33712513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inefficient clearance of myelin debris by microglia impairs remyelinating processes.
    Lampron A; Larochelle A; Laflamme N; Préfontaine P; Plante MM; Sánchez MG; Yong VW; Stys PK; Tremblay MÈ; Rivest S
    J Exp Med; 2015 Apr; 212(4):481-95. PubMed ID: 25779633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
    Fletcher JL; Wood RJ; Nguyen J; Norman EML; Jun CMK; Prawdiuk AR; Biemond M; Nguyen HTH; Northfield SE; Hughes RA; Gonsalvez DG; Xiao J; Murray SS
    J Neurosci; 2018 Aug; 38(32):7088-7099. PubMed ID: 29976621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuregulin-1 promotes remyelination and fosters a pro-regenerative inflammatory response in focal demyelinating lesions of the spinal cord.
    Kataria H; Alizadeh A; Shahriary GM; Saboktakin Rizi S; Henrie R; Santhosh KT; Thliveris JA; Karimi-Abdolrezaee S
    Glia; 2018 Mar; 66(3):538-561. PubMed ID: 29148104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia.
    Mecha M; Yanguas-Casás N; Feliú A; Mestre L; Carrillo-Salinas F; Azcoitia I; Yong VW; Guaza C
    Brain Behav Immun; 2019 Mar; 77():110-126. PubMed ID: 30582962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The flavonoid agathisflavone modulates the microglial neuroinflammatory response and enhances remyelination.
    de Almeida MMA; Pieropan F; de Mattos Oliveira L; Dos Santos Junior MC; David JM; David JP; da Silva VDA; Dos Santos Souza C; Costa SL; Butt AM
    Pharmacol Res; 2020 Sep; 159():104997. PubMed ID: 32534098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases.
    Lin Y; Huang G; Jamison S; Li J; Harding HP; Ron D; Lin W
    Am J Pathol; 2014 Feb; 184(2):507-19. PubMed ID: 24269558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.